Targeting signaling pathways involved with acquiring stemness, such as the Wnt/β-catenin, FGF, and NOTCH1 in HNSCC, may also be an attractive strategy to eliminate the CSCs and drug resistance. Here, NOTCH1 is linked to head and neck squamous cell carcinoma.